Company Info
Phone(646) 600-6438
Year Established
2020
Ticker
INAB
Exchange
NSDAQ
Contacts
William HoPresident, CEO & Co-Founder
Lawrence Lamb, Ph.D.
CSO & Co-Founder
Patrick McCall
CFO
Kate Rochlin, Ph.D.
COO
Trishna Goswami, M.D.
CMO
Company Description
IN8bio, formerly Incysus Therapeutics, is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T-cell product candidates for solid and liquid tumors.